Medical Scientist Training Program (MSTP)

Medical Scientist Training Program

Featured Student

uploadedImages/education/mstp/featured-students/keith-hazleton.jpg

Keith Hazleton

What has really made my time at Einstein a great experience is how tailored the MSTP is to the specific needs of an MD-PhD student. Starting from our specific histology, anatomy and physiology courses through the continuity clinic and career development seminars the program is really about being a physician-scientist, not a physician and a scientist.

 

The Medical Scientist Training Program (MSTP) at the Albert Einstein College of Medicine (Einstein) is one of the nation’s oldest. From the start, our goal has been to train a diverse group of outstanding students to become future leaders of academic medicine and medical research. Continuously funded by the National Institutes of Health since 1964, the Einstein MSTP has 428 illustrious Alumni with careers spanning the spectrum from basic science research to clinical medicine and many variations in between.

Today, the Einstein MSTP is still unique. Larger than most other MSTPs, it fosters a strong academic and social community within the college. While large enough to be an independent academic unit, the program is still small enough to provide students with the individual attention their unique careers require.

The current training program recognizes that the successful physician-scientist training is not simply medical school plus graduate training. The program integrates MSTP-specific courses with medical and graduate courses, during the first two years of preclinical course work. Integration continues in the PhD thesis years through weekly involvement in the MSTP Continuity Clinic and monthly Clinical Pathological Conferences and MSTP Career Paths seminars.

Students have outstanding publications and residency placements.

Awards & Accomplishments

  • Ali Zahalka NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Contributions of sympathetic signals to prostate cancer progression" (Sponsor,  Paul Frenette, Cell Biology)
  • Sean Healton NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Epigenetic activity of normal and cancer-associated mutant H1 linker histones" (Sponsor,  Arthur Skolutchi, Cell Biology)
  • Cary Weiss NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "MicroRNA-22 and the microRNA-22/tet2 network as regulators of the cell fate decision in hematopoietic stem cells and in the development of myelodysplastic syndrome" (Sponsor,  Keisuke Ito, Cell Biology)
  • Ruth Howe, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Characterizing the Novel Protein C15ORF65" (Sponsor,  Ulrich Steidl, Cell Biology)
  • Marika Osterbur, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Extra-coding features of mRNA are essential for hERG channel function" (Sponsor, Thomas McDonald, Molecular Pharmacology)
  • Karin Skalina, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Optimization of non-ablative focused ultrasound therapy for tumor immunity" (Sponsor, Chandan Guha, Pathology)
  • Michael Willcockson, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Regulators of the erythroid terminal differentiation decision and their connection to the cell cycle" (Sponsor, Art Skoultchi, Cell Biology)
  • Nelson Gil, NIH NRSA F31 Individual Predoctoral Fellowship Award for a project entitled "The molecular basis of receptor-ligand recognition on the immunological synapse" (Sponsor, Andras Fiser, Systems & Computational Biology)
  • Odelya Kaufman, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "The role of RBPMS2 in establishing oocyte polarity" (Sponsor, Florence Marlow, Developmental & Molecular Biology)
  • Kim Ohaegbulam, NIH NRSA F31 Individual Predoctoral Fellowship Award for a project entitled "Tumor expressed B7x accelerates disease and is a novel target for immunotherapy" (Sponsor, Xingxing Zang, Microbiology & Immunology)
  • Jennifer Schloss, NIH NRSA F30 Individual Predoctoral Fellowship Award for a project entitled "Use of beta cell epitopes in preventing type 1 diabetes in humanized mice" (Sponsor, Teresa DiLorenzo, Microbiology & Immunology)
  • Onyi Uchime, NIH NRSA F31 Individual Predoctoral Fellowship Award for a project entitled "Novel investigation of the mechanism of BAX modulation" (Sponsor, Evripidis Gavathiotis, Biochemistry)

 more awards 

Publications

  • publicationsKoirala P, Roth ME, Gill J, Piperdi S, Chinai JM, Geller DS, Hoang BH, Park A, Fremed MA, Zang X, Gorlick R. Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma. Sci Rep. 2016 Jul 26.
  • publications Wijetunga NA, Belbin TJ, Burk RD, Whitney K, Abadi M, Greally JM, Einstein MH, Schlecht NF. Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia. Gynecol Oncol. 2016 Jul 9. [Epub ahead of print].
  • publications Wen J, Stock AD, Chalmers SA, Putterman C. The role of B cells and autoantibodies in neuropsychiatric lupus. Autoimmun Rev. 2016 Jul 4. [Epub ahead of print].
  • publications Arora A, Deniskin R, Sosa Y, Nishtala SN, Henrich PP, Kumar TR, Fidock DA, Akabas MH. Substrate and inhibitor specificity of the Plasmodium berghei Equilibrative Nucleoside Transporter Type 1 (PbENT1). Mol Pharmacol. 2016 Jun
  • publications Raveh B*, Karp JM*, Sparks S*, Dutta K, Rout MP, Sali A, Cowburn D. Slide-and-exchange mechanism for rapid and selective transport through the nuclear pore complex. Proc Natl Acad Sci U S A. 2016 Apr. *contributed equally
  • publications Fang FC, Bowen A, Casadevall A. NIH peer review percentile scores are poorly predictive of grant productivity. Elife. 2016

more publications 

Click here to log in
Medical Scientist Training Program (MSTP)